Annette S. Uss

736 total citations
16 papers, 586 citations indexed

About

Annette S. Uss is a scholar working on Oncology, Hepatology and Infectious Diseases. According to data from OpenAlex, Annette S. Uss has authored 16 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Hepatology and 4 papers in Infectious Diseases. Recurrent topics in Annette S. Uss's work include Drug Transport and Resistance Mechanisms (7 papers), Hepatitis C virus research (6 papers) and Drug Solubulity and Delivery Systems (3 papers). Annette S. Uss is often cited by papers focused on Drug Transport and Resistance Mechanisms (7 papers), Hepatitis C virus research (6 papers) and Drug Solubulity and Delivery Systems (3 papers). Annette S. Uss collaborates with scholars based in United States, United Kingdom and China. Annette S. Uss's co-authors include Zhi Hong, Johnson Y. N. Lau, Eric Ferrari, KC Cheng, Weidong Zhong, Cheng Li, Piyun Chao, Jacquelyn Wright-Minogue, C. Cheng Kao and Tongtong Liu and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Virology and Biochemical and Biophysical Research Communications.

In The Last Decade

Annette S. Uss

16 papers receiving 555 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annette S. Uss United States 11 202 171 114 102 100 16 586
Qingjiao Liao China 11 181 0.9× 85 0.5× 57 0.5× 135 1.3× 110 1.1× 17 535
Nai-Wan Hsiao Taiwan 9 124 0.6× 186 1.1× 31 0.3× 214 2.1× 88 0.9× 10 571
Atsuya Yamashita Japan 20 252 1.2× 264 1.5× 62 0.5× 292 2.9× 147 1.5× 52 973
Muhammad Idrees Pakistan 14 342 1.7× 135 0.8× 72 0.6× 218 2.1× 166 1.7× 68 822
Juliane Gentzsch Germany 12 119 0.6× 292 1.7× 22 0.2× 244 2.4× 51 0.5× 12 523
Hao‐Jen Hsu Taiwan 16 285 1.4× 37 0.2× 68 0.6× 98 1.0× 195 1.9× 47 709
Mami Matsuda Japan 20 363 1.8× 385 2.3× 36 0.3× 401 3.9× 230 2.3× 42 1.1k
Garry Lund Canada 12 122 0.6× 152 0.9× 19 0.2× 232 2.3× 75 0.8× 21 501
R. Vrijsen Belgium 18 336 1.7× 172 1.0× 28 0.2× 197 1.9× 309 3.1× 46 1.0k
A. C. Looman Germany 11 405 2.0× 60 0.4× 72 0.6× 70 0.7× 30 0.3× 17 768

Countries citing papers authored by Annette S. Uss

Since Specialization
Citations

This map shows the geographic impact of Annette S. Uss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annette S. Uss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annette S. Uss more than expected).

Fields of papers citing papers by Annette S. Uss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annette S. Uss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annette S. Uss. The network helps show where Annette S. Uss may publish in the future.

Co-authorship network of co-authors of Annette S. Uss

This figure shows the co-authorship network connecting the top 25 collaborators of Annette S. Uss. A scholar is included among the top collaborators of Annette S. Uss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annette S. Uss. Annette S. Uss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Cheng, KC, et al.. (2011). Current drug discovery strategies for treatment of hepatitis C virus infection. Journal of Pharmacy and Pharmacology. 63(7). 883–892. 3 indexed citations
2.
Chao, Piyun, Annette S. Uss, & KC Cheng. (2010). Use of intrinsic clearance for prediction of human hepatic clearance. Expert Opinion on Drug Metabolism & Toxicology. 6(2). 189–198. 42 indexed citations
3.
Chang, Lee-Jah, Annette S. Uss, Inhou Chu, et al.. (2009). The impact of protein on Caco-2 permeability of low mass balance compounds for absorption projection and efflux substrate identification. Journal of Pharmaceutical and Biomedical Analysis. 51(5). 1069–1077. 14 indexed citations
4.
Chen, Jun, Cindy Tran, Xiao Li, et al.. (2009). Co-Induction of CYP3A12 and 3A26 in Dog Liver Slices by Xenobiotics: Species Difference Between Human and Dog CYP3A Induction. Drug Metabolism Letters. 3(1). 61–66. 11 indexed citations
5.
Chen, Kevin, Bancha Vibulbhan, Tongtong Liu, et al.. (2009). The Role of P-Glycoprotein in the Pharmacokinetics and Tissue Distribution of a Hepatitis C Virus Protease Inhibitor. Drug Metabolism Letters. 3(4). 290–295. 1 indexed citations
6.
Cheng, Kui, Cheng Li, Tongtong Liu, et al.. (2009). Use of Pre-Clinical In Vitro and In Vivo Pharmacokinetics for the Selection of a Potent Hepatitis C Virus Protease Inhibitor, Boceprevir, for Clinical Development. Letters in Drug Design & Discovery. 6(4). 312–318. 8 indexed citations
7.
Li, Cheng, Tongtong Liu, Lisa Broske, et al.. (2008). Permeability evaluation of peptidic HCV protease inhibitors in Caco-2 cells-correlation with in vivo absorption predicted in humans. Biochemical Pharmacology. 76(12). 1757–1764. 10 indexed citations
8.
Cheng, KC, Cheng Li, & Annette S. Uss. (2008). Prediction of oral drug absorption in humans – from cultured cell lines and experimental animals. Expert Opinion on Drug Metabolism & Toxicology. 4(5). 581–590. 62 indexed citations
9.
Li, Cheng, Latha G. Nair, Fangbiao Li, et al.. (2007). Correlation between PAMPA permeability and cellular activities of hepatitis C virus protease inhibitors. Biochemical Pharmacology. 75(5). 1186–1197. 24 indexed citations
10.
Li, Cheng, Tongtong Liu, Xiaoming Cui, Annette S. Uss, & K.-C. Cheng. (2007). Development of In Vitro Pharmacokinetic Screens Using Caco-2, Human Hepatocyte, and Caco-2/Human Hepatocyte Hybrid Systems for the Prediction of Oral Bioavailability in Humans. SLAS DISCOVERY. 12(8). 1084–1091. 49 indexed citations
11.
Garlisi, Charles G., Annette S. Uss, Hong Xiao, et al.. (2001). A Unique mRNA Initiated within a Middle Intron of WHSC1/MMSET Encodes a DNA Binding Protein That Suppresses Human IL-5 Transcription. American Journal of Respiratory Cell and Molecular Biology. 24(1). 90–98. 36 indexed citations
12.
Zhong, Weidong, Annette S. Uss, Eric Ferrari, Johnson Y. N. Lau, & Zhi Hong. (2000). De Novo Initiation of RNA Synthesis by Hepatitis C Virus Nonstructural Protein 5B Polymerase. Journal of Virology. 74(4). 2017–2022. 162 indexed citations
13.
Zhong, Weidong, Paul Ingravallo, Jacquelyn Wright-Minogue, et al.. (1999). Nucleoside Triphosphatase and RNA Helicase Activities Associated with GB Virus B Nonstructural Protein 3. Virology. 261(2). 216–226. 19 indexed citations
14.
Lai, Vicky C. H., C. Cheng Kao, Eric Ferrari, et al.. (1999). Mutational Analysis of Bovine Viral Diarrhea Virus RNA-Dependent RNA Polymerase. Journal of Virology. 73(12). 10129–10136. 94 indexed citations
15.
Uss, Annette S., et al.. (1998). Characterization of the Mouse Interleukin-5 Promoter in a Mouse TH2 T Cell Clone. Biochemical and Biophysical Research Communications. 252(1). 56–62. 3 indexed citations
16.
Uss, Annette S., et al.. (1997). Identification of Transcription Factor Binding Sites Important in the Regulation of the Human Interleukin-5 Gene. Journal of Biological Chemistry. 272(26). 16453–16465. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026